Linking Infectious and Narcology Care in Russia (LINC)
Linking Russian Narcology & HIV Care to Enhance Treatment, Retention, & Outcomes
研究概览
详细说明
The objective of this study "Linking Infectious and Narcology Care (LINC)" is to improve upon the treat and retain dimensions of the "seek, test, treat, and retain" paradigm in Eastern Europe. We will implement and assess a behavioral and structural intervention in Russia designed to support and motivate HIV-infected narcology heroin dependent patients (i.e., IDUs) to engage (i.e., initiate and retain) in HIV medical care and ultimately improve their HIV outcomes.
LINC is a clinical model designed to coordinate narcology and HIV systems of care using elements shown to facilitate engagement in medical care: HIV case management and point-of-care CD4 testing. The central hypothesis is that an intervention that involves coordination between the narcology and HIV systems via HIV case management delivered by a peer to help motivate and reduce barriers to HIV care will lead to engagement in HIV care.
Implementation research recognizes that effective interventions may not translate successfully across different contexts and systems. Hence, we will assess the organizational and operational issues that drive engagement in HIV care in Russia.
The project will be undertaken by an international research team experienced in addressing HIV, substance use, and clinical interventions in Russia. This proposal's Specific Aims are to assess the effectiveness of the LINC intervention compared to standard of care on 4 distinct outcomes: 1) initiation of HIV care (> 1 visit to HIV medical care) within 6 months of enrollment; 2) retention in HIV care (> 1 visit to medical care in 2 consecutive 6 month periods) within 12 months; 3) appropriate HIV care (prescribed ART if CD4 cell count is <350 or having a second CD4 count if CD4 ≥350 within 12 months; and 4) improved HIV health outcomes (CD4 cell count at 12 months). The final Specific Aim is to establish the contextual factors that influence adoption and sustainability of the LINC intervention in Russia. If LINC can embed effectively within Eastern European medical systems, then it has the potential to be widely implemented in this region of the world and have a major impact on the HIV epidemic among IDUs.
研究类型
注册 (实际的)
阶段
- 不适用
联系人和位置
学习地点
-
-
-
St. Petersburg、俄罗斯联邦
- City Addiction Hospital
-
St. Petersburg、俄罗斯联邦
- Pavlov State Medical University
-
St. Petersburg、俄罗斯联邦
- Botkin Infectious Disease Hospital
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- age 18 - 70 years
- HIV-infected
- hospitalized at a narcology hospital
- history of injection drug use
- available for CD4 testing
- has 2 contacts to assist with follow-up
- lives within 100 km of St. Petersburg, Russia
- has telephone
- willing to receive care at Botkin Infectious Disease Hospital
Exclusion Criteria:
- currently on ART
- not fluent in Russian
- cognitive impairment precluding informed consent
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:单身的
武器和干预
参与者组/臂 |
干预/治疗 |
---|---|
无干预:Standard of Care
Control participants will receive the narcology hospital's standard of care.
With regard to linkage to HIV medical care, patients will be given printed information about where to obtain HIV medical care - the outpatient clinic that is involved in the intervention.
Control patients will be referred to outpatient narcology care as part of standard of care.
If control participants are newly diagnosed with HIV infection at the addiction hospital, they will receive HIV post test counseling consistent with CDC recommendations (this represents an enhancement of the current standard of care in Russia).
|
|
实验性的:LINC Case Management (Intervention)
LINC Case Management (study Intervention) - see Intervention description
|
The 1st case management (CM) session will be at the Narcology Hospital and will follow a modified strengths-based case management curriculum.
As part of this first session, the CM will show a 10 minute video clip produced by a Russian NGO of HIV-infected patients talking about accessing HIV care.
The CM will also tell the patient what his/her CD4 cell count is and discuss what it means with the patient.
The case manager will help the client identify the outpatient HIV clinic on a map and will discuss basic drug harm reduction ideas with the client.
The remaining 4 CM sessions will happen over the following 6 months.
Sessions may happen at the HIV clinic, NGOs, or in the community.
The HIV CM helps the client understand the importance of HIV care, identify barriers to care acquisition and recognize one's own strengths, abilities and assets to reduce self-identified barriers to care.
The HIV CM's primary aim is to have the client attend an appointment at the HIV outpatient clinic.
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
---|---|---|
1) initiation of HIV care
大体时间:6 months
|
Greater than or equal to 1 visit to HIV medical care within 6 months of enrollment
|
6 months
|
2) retention in HIV care
大体时间:12 months
|
Greater than or equal 1 visit to medical care in 2 consecutive 6 month periods within 12 months
|
12 months
|
3) appropriate HIV care
大体时间:12 months
|
prescribed ART if CD4 cell count is less than 350 or having a second CD4 count if CD4 is greater than or equal to 350 within 12 months (Note: As guidelines change over time, this outcome may be updated accordingly.)
|
12 months
|
4) improved HIV health outcomes
大体时间:12 months
|
CD4 cell count at 12 months (compared to CD4 cell count at baseline)
|
12 months
|
5) Establish the contextual factors that influence adoption and sustainability of the LINC intervention in Russia
大体时间:4 years
|
Qualitative implementation science analysis, including pre-implementation focus groups, interviews, and surveys in Russia; post-implementation qualitative interviews in Russia.
|
4 years
|
合作者和调查者
调查人员
- 首席研究员:Jeffrey Samet, MD, MA, MPH、Boston Medical Center
出版物和有用的链接
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (估计)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.
爱滋病毒感染的临床试验
-
Hospital Clinic of Barcelona完全的
-
Centers for Disease Control and PreventionGilead Sciences; CDC Foundation完全的
-
Rajavithi Hospital未知研究在放疗前和放疗最后一周接受放疗的 HIV 癌症患者的免疫状态 | 研究在放疗前和放疗最后一周接受放疗的 HIV 癌症患者的 HIV 病毒载量泰国
-
National Institute of Allergy and Infectious Diseases...完全的HIV-1 感染 | HIV抗体 | 中和抗体 | 病毒载量 | 单克隆抗体美国
-
AIDS Healthcare FoundationUniversity of California, Los Angeles完全的
-
ANRS, Emerging Infectious DiseasesInstitut National de la Santé Et de la Recherche Médicale, France; University of Bergen; Centre... 和其他合作者完全的
-
Hospital Universitari Vall d'Hebron Research InstituteGilead Sciences完全的
-
Hospital Universitari Vall d'Hebron Research InstituteUniversity Hospital, Ghent; IrsiCaixa完全的
LINC Case Management的临床试验
-
University of Wisconsin, MadisonNational Institute on Aging (NIA); Oregon Health and Science University; University of Texas Southwestern...完全的
-
University of Wisconsin, MadisonUniversity of Alabama at Birmingham; National Institute on Aging (NIA); University of California... 和其他合作者邀请报名
-
University of Wisconsin, MadisonJohns Hopkins University; University of Colorado, Denver; Northwestern University; Columbia University 和其他合作者主动,不招人肾脏疾病 | 肾功能衰竭,慢性 | 沟通 | 晚期肾脏疾病 | 姑息治疗 | 生命尽头 | 透析 | 肾透析 | 决策 | 决策辅助 | 决策支持技术 | 肾病专家 | 晚期肾病 | 生命支持治疗美国
-
University of California, San FranciscoNational Institute on Aging (NIA); Mount Zion Health Fund主动,不招人
-
University of North Carolina, CharlotteNational Institute of Mental Health (NIMH)尚未招聘